NCT00113841View on ClinicalTrials.gov

Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Multiple Myeloma
Interventions
DRUG

Curcumin

2 grams (Capsules) orally in 2 divided doses (a.m., p.m.)

DRUG

Bioperine

5 mg (Tablets) orally twice daily

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00113841 - Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter